Articles about 'Department of Chemical Engineering and Biotechnology'

Solutions are being developed at Cambridge that can be implemented, grown to scale, and used to accelerate the rapid transition to a net zero and then zero emissions economy.

Vector Bioscience has received a £2.2 million investment to help it take forward its drug delivery platform designed to make RNA cancer therapies more effective.

Psychiatrist, Professor of Neurotechnology and 'Enterprising Mind', Sabine Bahn has founded two companies both with the aim of helping people with mental health disorders get a faster diagnosis and better access to the right treatment.

Researchers have used isotopes of carbon to trace how carbon dioxide emissions could be converted into low-carbon fuels and chemicals. The result could help the chemical industry, which is the third largest subsector in terms of direct CO2 emissions, recycle its own waste using current manufacturing processes.

Air travel is one of the major contributors to global warming. Cambridge scientists are working with leading energy companies to help develop sustainable aviation fuels, which could reduce the industry’s carbon emissions by up to 80%.

Water – which makes up the majority of every cell in the body – plays a key role in how proteins, including those associated with Parkinson’s disease, fold, misfold, or clump together, according to a new study.

Researchers have shown that aggregation of amyloid-beta, one of two key proteins implicated in Alzheimer’s disease, causes cells to overheat and ‘fry like eggs.’

A team of researchers from the UK and Japan has found that the tiny defects which limit the efficiency of perovskites – cheaper alternative materials for solar cells – are also responsible for structural changes in the material that lead to degradation.

How do you deal with a harmful invasive species wreaking havoc on the UK’s water pipes? You take advantage of them being fussy eaters and send them a Trojan Horse.

Researchers have used a combination of automated text analysis and the ‘robot scientist’ Eve to semi-automate the process of reproducing research results. The problem of lack of reproducibility is one of the biggest crises facing modern science.